110474 ⎘
ssDNA viruses; Details; Circoviridae Virus like particles [VLP]
PCV2 ORF2 PROTEIN VARIANT AND VIRUS LIKE PARTICLES COMPOSED THEREOF
#2PCV2 ORF2 protein variant and virus like particles composed thereof
#3PORCINE CIRCOVIRUS TYPE 2 VLP VACCINE
#4RECOMBINANT CIRCOVIRUS CAPSID-VIRUS-LIKE PARTICLE (VLP): COMPOSITIONS, METHODS AND USES
#5Recombinant vector for expressing virus-like particles in plant and method for preparation of vaccine composition containing circovirus-like particles by using same
#6PCV2 ORF2 protein variant and virus like particles composed thereof
#7IMMUNOGENIC COMPOSITION AND METHOD OF ENHANCING IMMUNE RESPONSE IN HOSTS
#8Recombinant expression of PCV2b ORF2 protein in insect cells
#9PCV2 ORF2 protein variant and virus like particles composed thereof
#10PCV2 ORF2 carrier platform
#11Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#12PCV2 ORF2 protein variant and virus like particles composed thereof
#13Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#14Recombinant antigens of porcine circovirus 2 (PCV-2) for vaccine formulations, diagnostic kit and use thereof
#15Methods for the Release of Virus-Like Particles
#16Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#17PCV2 ORF2 protein variant and virus like particles composed thereof
#18Methods for the release of Virus-like Particles
#19Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#20PCV2 ORF2 VIRUS LIKE PARTICLE WITH FOREIGN AMINO ACID INSERTION
#21USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS
#22Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#23Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#24USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS
#25Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#26Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#27USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS